These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 22446330)
1. Synthetic retinoid CD437 induces apoptosis and acts synergistically with TRAIL receptor-2 agonist in malignant melanoma. Magnussen GI; Ree Rosnes AK; Shahzidi S; Dong HP; Emilsen E; Engesæter B; Flørenes VA Biochem Biophys Res Commun; 2012 Apr; 420(3):516-22. PubMed ID: 22446330 [TBL] [Abstract][Full Text] [Related]
2. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells. Sun SY; Yue P; Hong WK; Lotan R Cancer Res; 2000 Dec; 60(24):7149-55. PubMed ID: 11156424 [TBL] [Abstract][Full Text] [Related]
3. Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells. Sun SY; Yue P; Lotan R Oncogene; 2000 Sep; 19(39):4513-22. PubMed ID: 11002424 [TBL] [Abstract][Full Text] [Related]
4. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells. Sun SY; Yue P; Hong WK; Lotan R Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825 [TBL] [Abstract][Full Text] [Related]
5. Synthetic retinoid CD437 induces apoptosis of esophageal squamous HET-1A cells through the caspase-3-dependent pathway. Wan X; Duncan MD; Nass P; Harmon JW Anticancer Res; 2001; 21(4A):2657-63. PubMed ID: 11724335 [TBL] [Abstract][Full Text] [Related]
6. Fenretinide up-regulates DR5/TRAIL-R2 expression via the induction of the transcription factor CHOP and combined treatment with fenretinide and TRAIL induces synergistic apoptosis in colon cancer cell lines. Kouhara J; Yoshida T; Nakata S; Horinaka M; Wakada M; Ueda Y; Yamagishi H; Sakai T Int J Oncol; 2007 Mar; 30(3):679-87. PubMed ID: 17273769 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid. Fontana JA; Sun RJ; Rishi AK; Dawson MI; Ordónez JV; Zhang Y; Tschang SH; Bhalla K; Han Z; Wyche J; Poirer G; Sheikh MS; Shroot B; Reichert U Oncol Res; 1998; 10(6):313-24. PubMed ID: 9848102 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of lexatumumab-induced apoptosis in human solid cancer cells by Cisplatin in caspase-dependent manner. Wu XX; Kakehi Y Clin Cancer Res; 2009 Mar; 15(6):2039-47. PubMed ID: 19276256 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells. Sun SY; Yue P; Wu GS; El-Deiry WS; Shroot B; Hong WK; Lotan R Oncogene; 1999 Apr; 18(14):2357-65. PubMed ID: 10327056 [TBL] [Abstract][Full Text] [Related]
10. Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells. Zang Y; Beard RL; Chandraratna RA; Kang JX Cell Death Differ; 2001 May; 8(5):477-85. PubMed ID: 11423908 [TBL] [Abstract][Full Text] [Related]
11. Caspase-dependent molecular mechanisms of anti-human DR5 monoclonal antibody mDRA-6 inducing apoptosis of human leukemia Jurkat cells. Du YW; Liu GC; Wang J; Zhao YP; Li SL; Chen JG; Jiang Q; Cai J; Ma YF Ai Zheng; 2009 Feb; 28(2):112-6. PubMed ID: 19550122 [TBL] [Abstract][Full Text] [Related]
12. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells. Sun SY; Yue P; Wu GS; El-Deiry WS; Shroot B; Hong WK; Lotan R Cancer Res; 1999 Jun; 59(12):2829-33. PubMed ID: 10383141 [TBL] [Abstract][Full Text] [Related]
13. Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells. Jin F; Liu X; Zhou Z; Yue P; Lotan R; Khuri FR; Chung LW; Sun SY Cancer Res; 2005 Jul; 65(14):6354-63. PubMed ID: 16024638 [TBL] [Abstract][Full Text] [Related]
14. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells. Cuello M; Ettenberg SA; Nau MM; Lipkowitz S Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126 [TBL] [Abstract][Full Text] [Related]
15. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin. Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094 [TBL] [Abstract][Full Text] [Related]
16. The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cells. Sun SY; Yue P; Chen X; Hong WK; Lotan R Cancer Res; 2002 Apr; 62(8):2430-6. PubMed ID: 11956107 [TBL] [Abstract][Full Text] [Related]
17. Lexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model. Zhang L; Zhang X; Barrisford GW; Olumi AF Cancer Lett; 2007 Jun; 251(1):146-57. PubMed ID: 17184908 [TBL] [Abstract][Full Text] [Related]
18. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response. Jiang CC; Chen LH; Gillespie S; Kiejda KA; Mhaidat N; Wang YF; Thorne R; Zhang XD; Hersey P Cancer Res; 2007 Jun; 67(12):5880-8. PubMed ID: 17575157 [TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation. Kim EH; Yoon MJ; Kim SU; Kwon TK; Sohn S; Choi KS Cancer Res; 2008 Jan; 68(1):266-75. PubMed ID: 18172319 [TBL] [Abstract][Full Text] [Related]
20. GADD45A is a mediator of CD437 induced apoptosis in ovarian carcinoma cells. Jiang T; Soprano DR; Soprano KJ J Cell Physiol; 2007 Sep; 212(3):771-9. PubMed ID: 17474084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]